Predictive Values of Procalcitonin for Coinfections in Patients with COVID-19: a Systematic Review and Meta-analysis

Overview

Journal Virol J

Publisher Biomed Central

Specialty Microbiology

Date 2023 May 9

PMID 37158904

Authors

Shanchen Wei

Lina Wang

Lianjun Lin

Xinmin Liu

Affiliations

Soon will be listed here.

Abstract

Objectives: To assess the ability of procalcitonin (PCT)-a promising marker for coinfections-to predict coinfections in patients with COVID-19.

Methods: In this systematic review and meta-analysis, PubMed, Embase, Web of Science, Cochrane, the China National Knowledge Infrastructure (CNKI), and Wanfang were searched to identify eligible studies (up to August 30, 2021). Articles that reported the predictive value of PCT for coinfections in patients with COVID-19 were included. Individual and pooled sensitivities and specificities were reported, and I was used to test heterogeneity. This study was prospectively registered on the International Prospective Register of Systematic Reviews (PROSPERO) database (registration number: CRD42021283344).

Results: Five studies involving a total of 2775 patients reported the predictive value of PCT for coinfections in patients with COVID-19. The sensitivity, specificity, and area under the curve of PCT in predicting coinfections in the pooled studies were 0.60 (95% CI 0.35-0.81, I = 88.85), 0.71 (95% CI 0.58-0.81, I = 87.82), and 0.72(95% CI 0.68-0.76) respectively.

Conclusions: Although PCT has limited predictive value for coinfections in patients with COVID-19, lower PCT levels seem to indicate a decreased probability of having a coinfection.

Citing Articles

Hematocrit and Albumin Levels at Admission Predict in-Hospital Mortality in Pediatric COVID-19 Omicron Variant Patients.

Zhu Y, Li L, Wang W, Liu X, Zhang M, Chen X Infect Drug Resist. 2024; 17:4067-4078.

PMID: 39309070 PMC: 11416771. DOI: 10.2147/IDR.S479580.

To prescribe or not: a two-center retrospective observational study of antibiotics usage and outcomes of COVID-19 in Turkey.

Karakoc H, Aydin M, Ozcan S, Olcar Y, Sumlu E, Dindar E Sci Rep. 2024; 14(1):21031.

PMID: 39251674 PMC: 11384660. DOI: 10.1038/s41598-024-72086-8.

The utility of procalcitonin for identifying secondary infections in patients with influenza or COVID-19 receiving extracorporeal membrane oxygenation.

Patel K, Aden J, Sobieszczyk M, Marcus J Ther Adv Infect Dis. 2024; 11:20499361241255873.

PMID: 38883923 PMC: 11177733. DOI: 10.1177/20499361241255873.

Development and validation of machine learning-based models for predicting healthcare-associated bacterial/fungal infections among COVID-19 inpatients: a retrospective cohort study.

Wang M, Li W, Wang H, Song P Antimicrob Resist Infect Control. 2024; 13(1):42.

PMID: 38616284 PMC: 11017584. DOI: 10.1186/s13756-024-01392-7.

The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients.

Campani S, Talamonti M, DallAra L, Coloretti I, Gatto I, Biagioni E Antibiotics (Basel). 2023; 12(10).

PMID: 37887237 PMC: 10604665. DOI: 10.3390/antibiotics12101536.

References

Vanhomwegen C, Veliziotis I, Malinverni S, Konopnicki D, Dechamps P, Claus M . Procalcitonin accurately predicts mortality but not bacterial infection in COVID-19 patients admitted to intensive care unit. Ir J Med Sci. 2021; 190(4):1649-1652. PMC: 7811155. DOI: 10.1007/s11845-020-02485-z. View

Contou D, Claudinon A, Pajot O, Micaelo M, Longuet Flandre P, Dubert M . Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care. 2020; 10(1):119. PMC: 7475952. DOI: 10.1186/s13613-020-00736-x. View

Hsu J . How covid-19 is accelerating the threat of antimicrobial resistance. BMJ. 2020; 369:m1983. DOI: 10.1136/bmj.m1983. View

Van Berkel M, Kox M, Frenzel T, Pickkers P, Schouten J . Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?. Crit Care. 2020; 24(1):600. PMC: 7538269. DOI: 10.1186/s13054-020-03291-w. View

Kooistra E, Van Berkel M, van Kempen N, van Latum C, Bruse N, Frenzel T . Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients. Crit Care. 2021; 25(1):281. PMC: 8340482. DOI: 10.1186/s13054-021-03717-z. View

Burke D, Bujkiewicz S, Riley R . Bayesian bivariate meta-analysis of correlated effects: Impact of the prior distributions on the between-study correlation, borrowing of strength, and joint inferences. Stat Methods Med Res. 2016; 27(2):428-450. PMC: 5810917. DOI: 10.1177/0962280216631361. View

Rothe K, Feihl S, Schneider J, Wallnofer F, Wurst M, Lukas M . Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship. Eur J Clin Microbiol Infect Dis. 2020; 40(4):859-869. PMC: 7605734. DOI: 10.1007/s10096-020-04063-8. View

Clover B . Governance. PCT non-executives to hold clusters 'to account'. Health Serv J. 2011; 121(6243):4-5. View

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-513. PMC: 7135076. DOI: 10.1016/S0140-6736(20)30211-7. View

10.

Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C . Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med. 2008; 168(18):2000-7. DOI: 10.1001/archinte.168.18.2000. View

11.

Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M . Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017; 10:CD007498. PMC: 6485408. DOI: 10.1002/14651858.CD007498.pub3. View

12.

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

13.

Vaughn V, Gandhi T, Petty L, Patel P, Prescott H, Malani A . Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study. Clin Infect Dis. 2020; 72(10):e533-e541. PMC: 7499526. DOI: 10.1093/cid/ciaa1239. View

14.

Lansbury L, Lim B, Baskaran V, Lim W . Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020; 81(2):266-275. PMC: 7255350. DOI: 10.1016/j.jinf.2020.05.046. View

15.

Burkhardt O, Ewig S, Haagen U, Giersdorf S, Hartmann O, Wegscheider K . Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J. 2010; 36(3):601-7. DOI: 10.1183/09031936.00163309. View

16.

Langford B, So M, Raybardhan S, Leung V, Westwood D, MacFadden D . Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020; 26(12):1622-1629. PMC: 7832079. DOI: 10.1016/j.cmi.2020.07.016. View

17.

Martins-Filho P, Tavares C, Santos V . Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Intern Med. 2020; 76:97-99. PMC: 7177074. DOI: 10.1016/j.ejim.2020.04.043. View

18.

May M, Chang M, Dietz D, Shoucri S, Laracy J, Sobieszczyk M . Limited Utility of Procalcitonin in Identifying Community-Associated Bacterial Infections in Patients Presenting with Coronavirus Disease 2019. Antimicrob Agents Chemother. 2021; 65(4). PMC: 8097424. DOI: 10.1128/AAC.02167-20. View

19.

Rodriguez A, Aviles-Jurado F, Diaz E, Schuetz P, Trefler S, Sole-Violan J . Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis. J Infect. 2015; 72(2):143-51. DOI: 10.1016/j.jinf.2015.11.007. View

20.

Rawson T, Moore L, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M . Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing. Clin Infect Dis. 2020; 71(9):2459-2468. PMC: 7197596. DOI: 10.1093/cid/ciaa530. View